Case report: acute leukemia after semustine (methyl-CCNU) therapy.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D002430:Cecal Neoplasms / Q000188:drug therapy*; D003561:Cytarabine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000009:adverse effects*; D012673:Semustine / Q000009:adverse effects* / Q000627:therapeutic use
D009607:Nitrosourea Compounds; D003561:Cytarabine; D012673:Semustine